JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M801166200 on July 7, 2008

J. Biol. Chem., Vol. 283, Issue 36, 24760-24769, September 5, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/36/24760    most recent
M801166200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Häger, M.
Right arrow Articles by Durbeej, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Häger, M.
Right arrow Articles by Durbeej, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cib2 Binds Integrin {alpha}7Bβ1D and Is Reduced in Laminin {alpha}2 Chain-deficient Muscular Dystrophy*Formula

Mattias Häger{ddagger}, Maria Giulia Bigotti§1, Renata Meszaros{ddagger}1, Virginie Carmignac{ddagger}1, Johan Holmberg{ddagger}, Valérie Allamand||, Mikael Åkerlund{ddagger}, Sebastian Kalamajski{ddagger}, Andrea Brancaccio**, Ulrike Mayer{ddagger}{ddagger}, and Madeleine Durbeej{ddagger}2

From the {ddagger}Department of Experimental Medical Science, Division for Cell and Matrix Biology, University of Lund, 221 84 Lund, Sweden, §Department of Biochemistry, University of Rome La Sapienza, 00185 Rome, Italy, INSERM U582, 75651 Paris, France, ||Institut de Myologie, IFR14, Université Pierre et Marie Curie-Paris 6, UMR-S582, 75250 Paris, France, **Istituto di Chimica del Riconoscimento Molecolare, c/o Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, 00168 Rome, Italy, and {ddagger}{ddagger}School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, United Kingdom

Mutations in the gene encoding laminin {alpha}2 chain cause congenital muscular dystrophy type 1A. In skeletal muscle, laminin {alpha}2 chain binds at least two receptor complexes: the dystrophin-glycoprotein complex and integrin {alpha}7β1. To gain insight into the molecular mechanisms underlying this disorder, we performed gene expression profiling of laminin {alpha}2 chain-deficient mouse limb muscle. One of the down-regulated genes encodes a protein called Cib2 (calcium- and integrin-binding protein 2) whose expression and function is unknown. However, the closely related Cib1 has been reported to bind integrin {alpha}IIb and may be involved in outside-in-signaling in platelets. Since Cib2 might be a novel integrin {alpha}7β1-binding protein in muscle, we have studied Cib2 expression in the developing and adult mouse. Cib2 mRNA is mainly expressed in the developing central nervous system and in developing and adult skeletal muscle. In skeletal muscle, Cib2 colocalizes with the integrin {alpha}7B subunit at the sarcolemma and at the neuromuscular and myotendinous junctions. Finally, we demonstrate that Cib2 is a calcium-binding protein that interacts with integrin {alpha}7Bβ1D. Thus, our data suggest a role for Cib2 as a cytoplasmic effector of integrin {alpha}7Bβ1D signaling in skeletal muscle.


Received for publication, February 12, 2008 , and in revised form, June 10, 2008.

* This work was supported by grants from the Muscular Dystrophy Association and Association Française contre les Myopathies (to M. D.) and by the Wenner-Gren Foundations (to V. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1–3.

1 These authors contributed equally to this work.

2 To whom all correspondence should be addressed: University of Lund, Dept. of Experimental Medical Science, Division for Cell and Matrix Biology, BMC B12, 221 84 Lund, Sweden. Tel.: 46-46-222-08-12; Fax: 46-46-222-08-55; E-mail: madeleine.durbeej-hjalt{at}med.lu.se.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.